Articles

Articles | June 10, 2020
A Culture of Collaboration

Collaboration is a common thread at Privacy Analytics, running through all aspects of our culture and work. You feel it in our radically transparent quarterly town hall meetings, our ...
Articles | June 10, 2020
A Passion for Excellence

When I think about what passion looks like at Privacy Analytics, it’s a quiet, underlying drive to innovate and push for a better world. If there’s one thing that unifies our team’s diverse set of ...
Articles | May 4, 2020
One Year In: How the Opening of Health Canada’s Portal Affects You

Just over a year ago, Health Canada stipulated that all clinical trials documents needed to make their way onto its designated portal. And, like those entering a portal in popular fiction, everyone ...
Articles | April 15, 2020
Putting Our Passion into Action Against COVID-19

Privacy Analytics is wholly committed to the global effort to respond to COVID-19. We have the collective will, the personal urgency and the technical ability to make a meaningful difference in the ...
Articles | December 19, 2019
Turn Data Assets into Business Opportunity Under CCPA

Business Problem How the CCPA is changing the legislative landscape Since the California Consumer Privacy Act was signed in 2018, multiple other states have proposed or introduced similar, ...
Articles | November 21, 2019
Can You Comply Your Way to Greatness?

I recently heard something that stuck with me: “Nobody complies their way to greatness.” An interesting comment, and a relevant one for all of us in the clinical trial transparency domain. But is ...
Articles | September 26, 2019
When to Integrate Anonymization of Documents and Data

Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)?
Articles | September 26, 2019
Learning at Scale: Anonymizing Unstructured Data using AI/ML

Unstructured data, such as medical notes, pose unique challenges with regards to anonymization. Not having a traditional database means that you can’t point a software solution to it to transform ...
Articles | June 21, 2019
Early Impact of Health Canada’s New Guidelines

Health Canada has introduced new regulatory guidance for anonymizing clinical study reports. As background, Bill C-17 Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) was initiated to ...
Articles | March 18, 2019
How will GDPR continue to impact the future of Clinical Trials Data Sharing?

Event: Privacy Analytics’ Executive Round Table on the Future of Clinical Trials Data Sharing, September 18, 2018, London, England This invitation-only event was adjacent to the London DIA Global ...

Filter by Data Type

Categories